Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phenbiox is an Italian biotechnology company and a spin-off from the University of Bologna that specializes in the development of high-performance plant-derived active ingredients for the cosmetic and personal care industries. The company utilizes proprietary technologies such as Enzymatic Bioliquefaction and Hyperfermentation to extract bioactive compounds from plants and agro-food by-products. Their product portfolio includes ingredients for skin care, hair care, and nutricosmetics, focusing on efficacy, sustainability, and scientific validation. Phenbiox serves global cosmetic brands by providing innovative solutions for anti-aging, hydration, and protection against environmental stressors. By leveraging circular economy principles, the company transforms agricultural waste into high-value functional ingredients. Their research-driven approach ensures that all products are backed by rigorous analytical and in vitro testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phenbiox.